Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Bajaj Finserv Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesDivi's Laboratories Limited7.75344393624.9974
Domestic EquitiesSun Pharmaceutical Industries Limited7.528015223424.2707
Domestic EquitiesApollo Hospitals Enterprise Limited6.28632735520.2673
Domestic EquitiesCipla Limited5.446611681017.5600
Domestic EquitiesFortis Healthcare Limited3.832512741012.3562
Domestic EquitiesNeuland Laboratories Limited3.7776833912.1791
Domestic EquitiesBiocon Limited3.591533956811.5793
Domestic EquitiesDr. Reddy's Laboratories Limited3.43259043511.0665
Domestic EquitiesEmcure Pharmaceuticals Limited3.25548200210.4954
Domestic EquitiesDr. Lal Path Labs Limited3.23613346110.4335
Domestic EquitiesPiramal Pharma Limited3.233354531610.4243
Domestic EquitiesAurobindo Pharma Limited3.14999369510.1556
Domestic EquitiesGlenmark Pharmaceuticals Limited2.9654489619.5606
Domestic EquitiesPfizer Limited2.5489163188.2177
Domestic EquitiesLupin Limited2.1506362786.9338
Domestic EquitiesIPCA Laboratories Limited2.0966504836.7597
Domestic EquitiesSanofi Consumer Healthcare India Limited2.0298138636.5440
Domestic EquitiesZydus Wellness Limited1.95561379056.3050
Domestic EquitiesVijaya Diagnostic Centre Limited1.9143617186.1718
Domestic EquitiesGodrej Consumer Products Limited1.8097500005.8345
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.7280209475.5713
Domestic EquitiesShaily Engineering Plastics Limited1.6751248095.4007
Domestic EquitiesMedi Assist Healthcare Services Limited1.62691005905.2453
Domestic EquitiesAlkem Laboratories Limited1.607895555.1836
Domestic EquitiesAbbott India Limited1.578917385.0906
Domestic EquitiesTorrent Pharmaceuticals Limited1.4181126894.5721
Domestic EquitiesRainbow Childrens Medicare Limited1.2409295034.0006
Domestic EquitiesHindustan Unilever Limited1.2151155813.9177
Domestic EquitiesMedPlus Health Services Limited1.2135516523.9124
Domestic EquitiesMax Healthcare Institute Limited1.2101350003.9014
Domestic EquitiesJubilant Pharmova Limited1.1713349863.7764
Domestic EquitiesAlembic Pharmaceuticals Limited1.1168399473.6006
Domestic EquitiesMankind Pharma Limited1.0974145263.5381
Domestic EquitiesSyngene International Limited1.0652551393.4343
Domestic EquitiesAstraZeneca Pharma India Limited0.922732672.9748
Domestic EquitiesEmami Limited0.9182549992.9603
Domestic EquitiesMarico Limited0.6834315922.2032
Domestic EquitiesPB Fintech Limited0.519298361.6741
Domestic EquitiesNestle India Limited0.4968138921.6016
Domestic EquitiesNeogen Chemicals Limited0.439094321.4153
Domestic EquitiesCohance Lifesciences Limited0.3268119851.0536
Total 95.2652 307.1405
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd2.9712 9.5793
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-1.6733 -5.3947
Total 1.2979 4.1846
Derivatives-FuturesAurobindo Pharma Limited October 2025 Future3.436810175011.0806
Total 3.4368 11.0806
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.